Oncolytic virus (OV) therapy is an anti-cancer approach that uses viruses that preferentially
infect, replicate in and kill cancer cells. Vesicular stomatitis virus (VSV, a rhabdovirus) is an …

The oncolytic virotherapy field has made significant advances in the last decade, with a
rapidly increasing number of early-and late-stage clinical trials, some of them showing safety …

Introduction Studying cancer tumors' microenvironment may reveal a novel role in driving
cancer progression and metastasis. The biological interaction between stromal …

Oncolytic viruses are a promising anti-cancer platform, achieving significant pre-clinical and
clinical milestones in recent years. A full arsenal of selective, safe, and effective viruses has …

Vesicular Stomatitis Virus (VSV) has emerged as a promising candidate for various clinical
applications, including vaccine development, virus pseudotyping, and gene delivery. Its …

Objective Current adjuvant therapy for advanced-stage, recurrent, and high-risk endometrial
cancer (EC) has not reduced mortality from this malignancy, and novel systemic therapies …

There is a widespread interest in the development of aptamer-based affinity
chromatographic methods for purification of biomolecules. Regardless of the many …

Oncolytic viruses (OVs) represent a targeted anti-cancer therapy approach due to their
ability not only to selectively infect and destroy malignant cells but also to induce an immune …

According to the World Health Organization, cancer is the second leading cause of death in
the world. This serves as a powerful incentive to search for new effective cancer treatments …

Head and neck cancer (HNC) is the sixth most common malignancy worldwide. Despite
recent advancements in surgical, chemotherapy, and radiation treatments, HNC remains a …